Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients

BACKGROUND: Implication of pharmacogenetic variations and efavirenz pharmacokinetics in concomitant efavirenz based antiviral therapy and anti-tubercular drug induced liver injury (DILI) has not been yet studied. We performed a prospective case-control association study to identify the incidence, ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Yimer, Getnet, Ueda, Nobuhisa, Habtewold, Abiy, Amogne, Wondwossen, Suda, Akira, Riedel, Klaus-Dieter, Burhenne, Jürgen, Aderaye, Getachew, Lindquist, Lars, Makonnen, Eyasu, Aklillu, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232196/
https://www.ncbi.nlm.nih.gov/pubmed/22162992
http://dx.doi.org/10.1371/journal.pone.0027810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232196/
https://www.ncbi.nlm.nih.gov/pubmed/22162992
http://dx.doi.org/10.1371/journal.pone.0027810

Ejemplares similares